Cellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTb

Tuberculosis

Volumn 91, Issue 1, 2011, Pages 93-97

  Lawlor, C ^a,b   Kelly, C ^a   O'Leary, S ^b   O'Sullivan, M P ^b   Gallagher, P J ^a   Keane, J ^b   Cryan, S A ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Anti tubercular therapy; Drug delivery systems (DDS); Microparticle; Nanoparticle; Trafficking; Vaccine

Indexed keywords

ISONIAZID; POLYGLACTIN; POLYLACTIC ACID; PYRAZINAMIDE; RIFAMPICIN;

ANTIBIOTIC THERAPY; CELL MIGRATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; LUNG ALVEOLUS MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; MACROPHAGES, ALVEOLAR; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; TUBERCULOSIS, PULMONARY;

EID: 79551504863     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.12.001     Document Type: Review

References (45)

1. G. Rook, K. Dheda, and A. Zumla Immune responses to tuberculosis in developing countries: implications for new vaccines Nature Reviews in Immunology 5 2005 661 667
2. R. van Crevel, T.H.M. Ottenhoff, and J.W.M. van der Meer Innate immunity to Mycobacterium tuberculosis Clinical Microbiology Reviews 15 2002 294 309
3. P. O'Hara, and A. Hickey Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterisation Pharmaceutical Research 17 2000 956 961
4. J. Kreuter Nanoparticles and microparticles for drug and vaccine delivery Journal of Anatomy 189 Pt 3 1996 503 505
5. M. Qaddoumi, H. Ueda, J. Yang, J. Davda, V. Labhasetwar, and V. Lee The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers Pharmaceutical Research 21 2004 641 648
6. K. Hirota, T. Hasegawa, H. Hinata, F. Ito, H. Inagawa, and C. Kochi Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages Journal of Controlled Release 119 2007 69 76
7. Y. Tabata, and Y. Ikada Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation Pharmaceutical Research 6 1989 296 300
8. R. Sharma, D. Saxena, A.K. Dwivedi, and A. Misra Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis Pharmaceutical Research 18 2001 1405 1410
9. S. Suarez, P. O'Hara, M. Kazantseva, C.E. Newcomer, R. Hopfer, and D.N. McMurray Airways delivery of rifampicin microparticles for the treatment of tuberculosis Journal of Antimicrobial Chemotherapy 48 2001 431 434
10. A.B. Yadav, P. Muttil, A.K. Singh, R.K. Verma, M. Mohan, and A.K. Agrawal Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis Tuberculosis 90 2010 188 196
11. K. Makino, T. Nakajima, M. Shikamura, F. Ito, S. Ando, and C. Kochi Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin Colloids and Surfaces B: Biointerfaces 36 2004 35 42
12. P. Muttil, C. Wang, and A. Hickey Inhaled drug delivery for tuberculosis therapy Pharmaceutical Research 26 2009 2401 2416
13. J.D. Ernst Macrophage receptors for Mycobacterium tuberculosis Infection and Immunity 66 1998 1277 1281
14. L.S. Schlesinger, C.G. Bellinger-Kawahara, N.R. Payne, and M.A. Horwitz Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3 Journal of Immunology 144 1990 2771 2780
15. L.S. Schlesinger Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors Journal of Immunology 150 1993 2920 2930
16. D.W. Dunne, D. Resnick, J. Greenberg, M. Krieger, and K.A. Joiner The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid Proceedings of the National Academy of Sciences of the United States of America 91 1994 1863 1867
17. D.G. Russell Mycobacterium tuberculosis: here today, and here tomorrow Nature Reviews Molecular Cell Biology 2 2001 569 586
18. S.D. Conner, and S.L. Schmid Regulated portals of entry into the cell Nature 422 2003 37 44
19. A. Díaz-Moscoso, D. Vercauteren, J. Rejman, J.M. Benito, C. Ortiz Mellet, and S.C. De Smedt Insights in cellular uptake mechanisms of pDNA-polycationic amphiphilic cyclodextrin nanoparticles (CDplexes) Journal of Controlled Release 143 2010 318 325
20. J. Panyam, and V. Labhasetwar Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells Pharmaceutical Research 20 2003 212 220
21. P. Watson, A.T. Jones, and D.J. Stephens Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells Advanced Drug Delivery Reviews 57 2005 43 61
22. S.P. Vyas, M.E. Kannan, S. Jain, V. Mishra, and P. Singh Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages International Journal of Pharmaceutics 269 2004 37 49
23. C.G. Oster, N. Kim, L. Grode, L. Barbu-Tudoran, A.K. Schaper, and S.H.E. Kaufmann Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination Journal of Controlled Release 104 2005 359 377
24. M. Bivas-Benita, K.E. van Meijgaarden, K.L.M.C. Franken, H.E. Junginger, G. Borchard, and T.H.M. Ottenhoff Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A0201-restricted T-cell epitopes of Mycobacterium tuberculosis Vaccine 22 2004 1609 1615
25. G.W. Bos, T. Kanellos, D.J.A. Crommelin, W.E. Hennink, and C.R. Howard Cationic polymers that enhance the performance of HbsAg DNA in vivo Vaccine 23 2004 460 469
26. G. Borchard Chitosans for gene delivery Advanced Drug Delivery Reviews 52 2001 145 150
27. H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan Toxicity of cationic lipids and cationic polymers in gene delivery Journal of Controlled Release 114 2006 100 109
28. T. Merdan, J. Kopecek, and T. Kissel Prospects for cationic polymers in gene and oligonucleotide therapy against cancer Advanced Drug Delivery Reviews 54 2002 715 758
29. N. Brandhonneur, F. Chevanne, V. Vie, B. Frisch, R. Primault, and M.F. Le Potier Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages European Journal of Pharmaceutical Sciences 36 2009 474 485
30. H. Sun, K.G.J. Pollock, and J.M. Brewer Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro Vaccine 21 2003 849 855
31. F.A. Sharp, D. Ruane, B. Claass, E. Creagh, J. Harris, and P. Malyala Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome Proceedings of the National Academy of Sciences of the United States of America 106 2009 870 875
32. S. Shi, and A. Hickey PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B Pharmaceutical Research 27 2009 350 360
33. D.L. Clemens, and M.A. Horwitz Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited Journal of Experimental Medicine 181 1995 257 270
34. D.G. Russell, B.C. VanderVen, S. Glennie, H. Mwandumba, and R.S. Heyderman The macrophage marches on its phagosome: dynamic assays of phagosome function Nature Reviews in Immunology 9 2009 594 600
35. J. Panyam, W.-Z. Zhou, S. Prabha, S.K. Sahoo, and V. Labhasetwar Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery FASEB Journal 16 2002 1217 1226
36. D. Schmaljohann Thermo- and pH-responsive polymers in drug delivery Advanced Drug Delivery Reviews 58 2006 1655 1670
37. C. Tekle, Deurs Bv, K. Sandvig, and T.-G. Iversen Cellular trafficking of quantum dot-ligand bioconjugates and their induction of changes in normal routing of unconjugated ligands Nano Letters 8 2008 1858 1865
38. K. Hirota, T. Hasegawa, T. Nakajima, H. Inagawa, C. Kohchi, and G.-I. Soma Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis Journal of Controlled Release 142 2009 339 346
39. C.J. Chelen, Y. Fang, G.J. Freeman, H. Secrist, J.D. Marshall, and P.T. Hwang Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules Journal of Clinical Investigation 95 1995 1415 1421
40. A.A. Beharka, C.D. Gaynor, B.K. Kang, D.R. Voelker, F.X. McCormack, and L.S. Schlesinger Pulmonary surfactant protein a up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages Journal of Immunology 169 2002 3565 3573
41. P. Muttil, J. Kaur, K. Kumar, A.B. Yadav, R. Sharma, and A. Misra Inhalable microparticles containing large payload of anti-tuberculosis drugs European Journal of Pharmaceutical Sciences 32 2007 140 150
42. M. Dutt, and G.K. Khuller Therapeutic efficacy of poly(dl-lactide-co- glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice Antimicrobial Agents and Chemotherapy 45 2001 363 366
43. R. Pandey, and G.K. Khuller Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers Journal of Antimicrobial Chemotherapy 53 2004 635 640
44. A. Zahoor, S. Sharma, and G.K. Khuller Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis International Journal of Antimicrobial Agents 26 2005 298 303
45. A. Agarwal, H. Kandpal, H.P. Gupta, N.B. Singh, and C.M. Gupta Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice Antimicrobial Agents and Chemotherapy 38 1994 588 593